drugset / Trial / NCT01966328

A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment

NCT01966328 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

This research is studying the effect that Resolvine injection will have on patients with vitreomacular adhesion.

Timeline

Start
2013-10
Primary completion
2015-10
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Resolvine Unknown 9 % Intravitreal
Subject Resolvine Unknown 36 % Intravitreal

Indications